$353.24
1.37%
NYSE, Oct 10, 10:10 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$353.24
+46.49 15.16% 1M
-83.13 19.05% 6M
-15.66 4.25% YTD
-138.94 28.23% 1Y
-113.91 24.38% 3Y
+54.67 18.31% 5Y
+209.38 145.54% 10Y
+279.18 376.96% 20Y
NYSE, Closing price Fri, Oct 10 2025
-4.89 1.37%

Key metrics

Basic
Market capitalization
$79.5b
Enterprise Value
$101.2b
Net debt
$21.6b
Cash
$8.6b
Shares outstanding
224.8m
Valuation (TTM | estimate)
P/E
14.9 | 11.7
P/S
0.4 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
19.1
P/B
1.8
Dividends
DPS
$6.52
Yield 1Y | 5Y
1.9% | 1.2%
Growth 1Y | 5Y
10.1% | 15.3%
Payout 1Y | 3Y
25.4% | 23.4%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$189.3b | $198.9b
EBITDA
$9.3b | $10.6b
EBIT
$8.7b | $9.8b
Net Income
$5.4b | $6.8b
Free Cash Flow
$5.3b
Growth (TTM | estimate)
Revenue
10.2% | 12.5%
EBITDA
-14.3% | 9.1%
EBIT
-14.3% | 6.7%
Net Income
-19.9% | 13.5%
Free Cash Flow
562.3%
Margin (TTM | estimate)
Gross
-
EBITDA
4.9% | 5.3%
EBIT
4.6%
Net
2.8% | 3.4%
Free Cash Flow
2.8%
Financial Health
Equity Ratio
35.4%
Return on Equity
14.5%
ROCE
7.7%
ROIC
-
Debt/Equity
0.7
More
EPS
$23.7
FCF per Share
$23.5
Short interest
1.4%
Employees
104k
Rev per Employee
$1.7m
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,999 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

18x Buy
64%
10x Hold
36%

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

Buy
64%
Hold
36%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
189,254 189,254
10% 10%
100%
- Policy Benefits 138,467 138,467
13% 13%
73%
50,787 50,787
4% 4%
27%
- SG&A - -
-
-
- Other operating expenses 41,483 41,483
10% 10%
22%
9,304 9,304
14% 14%
5%
- Depreciation and Amortization 604 604
15% 15%
0%
8,700 8,700
14% 14%
5%
- Interest Expense 1,325 1,325
25% 25%
1%
- Tax Expense 1,719 1,719
9% 9%
1%
Net Profit 5,360 5,360
20% 20%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Positive
Seeking Alpha
9 days ago
Share of only a handful of large-cap US insurers finished the week in negative territory, while the majority of insurers were either flat or saw gains as Congress failed to reach an agreement to keep the federal government open. The S&P 500 was up about 1.1% for the week as of close of business Oct. 2 as the broader market seemed to brush off concerns associated with the shutdown.
Neutral
Business Wire
13 days ago
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888...
Positive
Seeking Alpha
16 days ago
Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line contraction and lowered FY2025 EPS guidance, but revenue growth remains robust, especially in its Carelon segment. Despite margin pressures from rising Medicaid and ACA costs, ELV maintains strong p...
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today